164 results
Page 3 of 9
424B5
0uwzsnn6mwi1
9 Nov 20
Prospectus supplement for primary offering
5:13pm
8-K
EX-99.1
neipjeq
10 Aug 20
TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
7:30am
424B5
5ssmili2
18 May 20
Prospectus supplement for primary offering
4:02pm
424B5
2dzwuis66fiuk5p
14 May 20
Prospectus supplement for primary offering
5:18pm
8-K
EX-99.1
r1aoitntdp64q8qy2p
11 May 20
TG Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
5:16pm
8-K
EX-99.1
zdupuougpwmf
5 May 20
Other Events
7:30am
8-K
j6hzwkk964a5jl3j
5 May 20
Other Events
7:30am
424B5
w6bdnp90h40ysh04p2
20 Mar 20
Prospectus supplement for primary offering
4:54pm
8-K
EX-99.1
235egl9r aq0z
3 Mar 20
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2019 Financial Results
7:22am
8-K
EX-99.2
9phpmfbum4z 0g759
9 Dec 19
Other Events
8:15am
8-K
fdzjahbvikxyx795ve
9 Dec 19
Other Events
8:15am
8-K
EX-99.1
3j1209
9 Dec 19
Other Events
8:15am
8-K
EX-99.1
y5ei8qu0etszjhd7uouv
28 Oct 19
Umbralisib monotherapy appeared to be well tolerated with a safety profile consistent with previous reports TG plans to present the data at a future medical conference and discuss the results with the FDA
7:59am
S-3ASR
1wl ihe7ue624hu
5 Sep 19
Automatic shelf registration
4:17pm